SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands |
May 12, 2025 |
Jun. 30, 2025 |
May 07, 2025 |
---|---|---|---|
Debt Instrument [Line Items] | |||
Cumulative proceeds from token offering | $ 467 | ||
Stock issuance costs incurred | 106 | ||
Unrealized loss on debt | $ 406 | ||
Additional Term Loan | Secured Debt | |||
Debt Instrument [Line Items] | |||
Principal amount | $ 5,200 | ||
Debt, percentage of outstanding common shares | 19.90% | ||
Debt, percent of outstanding shares, maximum | 65.00% | ||
Amended and Restated Credit Agreement | Secured Debt | |||
Debt Instrument [Line Items] | |||
Principal amount | $ 8,500 | ||
Amended and Restated Credit Agreement | Secured Debt | Fair value | |||
Debt Instrument [Line Items] | |||
Long-term debt, fair value | $ 8,500 |
X | ||||||||||
- Definition Debt Instrument, Convertible, Percentage Of Outstanding Common Shares No definition available.
|
X | ||||||||||
- Definition Debt Instrument, Covenant, Percent Of Outstanding Shares, Maximum No definition available.
|
X | ||||||||||
- Definition Noncontrolling Interest, Cumulative Proceeds From Token Offering No definition available.
|
X | ||||||||||
- Definition Stock Issuance Costs Incurred No definition available.
|
X | ||||||||||
- Definition Unrealized Gain (Loss) on Debt Instrument, Net No definition available.
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|